Skip to main content
. 2004 Feb;48(2):596–601. doi: 10.1128/AAC.48.2.596-601.2004

TABLE 3.

Comparative susceptibilities to six fluoroquinolones and distribution of MICs among isolatesa

MIC (mg/liter) % of strains or relative MICb
Moxifloxacin
Gatifloxacin
Sitafloxacin
Ofloxacin
Levofloxacin
Sparfloxacin
C S R− R+ C S R− R+ C S R− R+ C S R− R+ C S R− R+ C S R− R+
≤0.125 16 17 24 13 33 39 16 100 83 26
0.25 100 61 43 100 61 65 100 55 26 100 31 100 60 4 13 61 3
0.5 16 30 12 13 10 26 22 40 22 52 4 9 19
1 6 9 31 1 4 16 1 9 34 29 2 35 3 9
2 1 53 4 44 25 83 3 9 22 4 28
4 13 1 41 16 13 19 25 22
8 3 3 4 28 31
16 38 19 19
>16 13
MIC50 1 1 1 8 1 1 1 8 1 1 1 4 1 2 8 32 1 1 2 16 1 1 2 16
MIC90 1 2 2 16 1 2 2 16 1 2 2 16 1 4 16 >64 1 2 4 16 1 2 4 128
a

There were four categories of M tuberculosis strains: C, the two ATCC control strains; S, 83 ofloxacin-susceptible strains (ofloxacin MIC < 2 mg/liter); R−, 23 ofloxacin-resistant isolates without gyrA mutations (ofloxacin MIC ≥ 2mg/liter); and R+, 32 ofloxacin-resistant isolates with gyrA mutations (ofloxacin MIC ≥ 2mg/liter).

b

See Table 2, footnote a.